TARPLIN, DOWNS & YOUNG, LLC for GILEAD SCIENCES, INC.
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
H.R. 5376, the Build Back Better Act H.R. 2471, Consolidated Appropriations Act 2022 deficit reduction, reconciliation
| Lobbyist | Covered position, as disclosed |
|---|---|
| KIMBERLY LYNN BRANDT | Sr. Counsel and Dir. External Affairs - HHS OIG; Prin. Dep. Administrator for Policy and Operations and Dir. of Medicare Program Integrity - CMS; Chief Oversight and General Counsel - Senate Cmte. on Finance |
| RAISSA H DOWNS | Prin. Dep. Asst. Sec. for Leg. - HHS; Dep. Asst. Sec. for Leg. - HHS; Staff Dir., Sub. Cmte. on Employment, Sen. HELP Cmte. |
| MICHELLE P EASTON | Chief Health Counsel, Sen. Cmte. on Finance; Staff Dir., Senate Aging Cmte.; Leg. Asst., Congressman Billy Tauzin |
| CHARLOTTE SPEARS IVANCIC | Leg. Counsel, Sen. Jim DeMint; Health Counsel, Maj. Leader Bill Frist; Counsel and Budget Analyst, House Budget Cmte.; Asst. to the Speaker for Policy, Speaker John Boehner |
| ELIZABETH T MURRAY | Senior Policy Advisor, Democratic Whip Steny Hoyer; Legislative Asst. for Rep. Mike Thompson, Rep. Bob Matsui, and Senator Bob Graham |
| EMILY H MURRY | Staff Dir., Sub. Cmte. on Health, W&M Cmte; Sr. Policy Advisor, Majority Leader McCarthy; Policy Advisor, Majority Whip McCarthy; Professional Staff, Republican Study Cmte.; Leg. Aid, Rep. Ken Calvert; Leg. Asst., Rep. Tom Price |
| PAMELA SMITH | Leg. Dir., Sen. Tom Harkin; Dep. Staff Dir., Senate HELP Cmte; Staff Dir., Senate HELP Cmte; Counselor to the Asst. AG, Civil Div., Dept of Justice; Spec Counsel, Ofc of Leg. Affairs, Dept of Justice; Counsel and LA, Senator Carol Moseley-Braun |
| JENNIFER B YOUNG | Asst. Sec. for Leg. - HHS; Dep. Asst. Sec. for Leg. - HHS; Cmte. Staff, House Cmte. on Ways and Means; Cmte. Staff, Sen. Cmte. on Finance |
Health Issues HCR
H.R. 5376, the Build Back Better Act S. 4348, FDA Safety and Landmark Advancements Act H.R. 7667, Food and Drug Amendments of 2022 Pharmaceutical access and affordability, Ryan White, PEPFAR, 340B, HCV Screening, drug pricing and access, HIV, HCV, oncology, coronavirus therapeutics, FDA user fees
| Lobbyist | Covered position, as disclosed |
|---|---|
| KIMBERLY LYNN BRANDT | — |
| RAISSA H DOWNS | — |
| MICHELLE P EASTON | — |
| CHARLOTTE SPEARS IVANCIC | — |
| ELIZABETH T MURRAY | — |
| EMILY H MURRY | — |
| PAMELA SMITH | — |
| JENNIFER B YOUNG | — |
Medicare/Medicaid MMM
Six protected classes, Medicare Part D, HIV, Medicaid, Pharmaceutical access & affordability, Part D benefit redesign, Hepatitis C, HIV, Coronavirus therapeutics, Medicaid Value Based Payment rule
| Lobbyist | Covered position, as disclosed |
|---|---|
| KIMBERLY LYNN BRANDT | — |
| RAISSA H DOWNS | — |
| MICHELLE P EASTON | — |
| CHARLOTTE SPEARS IVANCIC | — |
| ELIZABETH T MURRAY | — |
| EMILY H MURRY | — |
| PAMELA SMITH | — |
| JENNIFER B YOUNG | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.